Invesaro

Stocks Health care RLX

NYSE · Health care

RLX Technology Inc. (RLX)

RLX Technology Inc. reported revenue of $566.1M in fiscal 2025, up 50.3% from a year earlier. Net income was $131.8M, a net margin of 23.3%. Operating cash flow minus capital spending left $141.1M of free cash flow in fiscal 2025. At December 31, 2025 it held $767.5M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on April 23, 2026.

Free, no password. An email when RLX files with the SEC.

Price
$1.59
-1.24% on the day · November 9, 2026
52-week range $1.58 to $2.60
Market cap
$2.5B
Revenue (FY2025)
$566.1M
+50.3% year on year
Net margin
23.3%

Key facts about RLX Technology Inc.

Net worth
RLX Technology Inc. has a market value (market cap) of $2.5B at the latest share price, and shareholders' equity of $2.2B on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $566.1M (+50.3% year on year), with net income of $131.8M.
Cash flow
In fiscal 2025 operations brought in $157.9M of cash; after $16.8M of capital spending, free cash flow was $141.1M.
Latest report
The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on April 23, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR
Dividend
RLX Technology Inc. declared dividends of $0.11 per share in fiscal 2025.

What RLX Technology Inc. does

RLX Technology Inc. is registered with the SEC under industry code SIC 2111 (Cigarettes). Its shares trade on NYSE under the ticker RLX.

Revenue and profit by year

Revenue
FY20: $585.4M $585.4M FY20FY21: $1.3B $1.3B FY21FY22: $773.2M $773.2M FY22FY23: $223.4M $223.4M FY23FY24: $376.6M $376.6M FY24FY25: $566.1M $566.1M FY25
Net income
FY20: -$19.6M -$19.6M FY20FY21: $317.7M $317.7M FY21FY22: $209M $209M FY22FY23: $75.3M $75.3M FY23FY24: $75.6M $75.6M FY24FY25: $131.8M $131.8M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$566.1M$47M$131.8M$0.10$141.1M
2024$376.6M-$14.7M$75.6M$0.06$115.7M
2023$223.4M-$70M$75.3M$0.06$24M
2022$773.2M$154.2M$209M$0.16$65M
2021$1.3B$360.7M$317.7M$0.23$261.9M
2020$585.4M$2M-$19.6M-$0.01$394.9M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Where RLX ranks in Health care

Revenue$566.1M
#196 of 751 in Health care · Top 26%
Revenue growth+50.3%
#97 of 532 in Health care · Top 18%
Net margin23.3%
#55 of 544 in Health care · Top 10%
Free cash flow margin24.9%
#34 of 490 in Health care · Top 7%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

RLX Technology Inc. declared $0.11 per share in fiscal 2025. It paid out $13.1M in cash dividends, 10% of its net income.

Fiscal yearPer sharePaid outOf profit
2025$0.11$13.1M10%
2024n/a$12.2M16%
2023n/a$13M17%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What RLX Technology Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 14, 2026
  2. May 20, 2026
  3. April 23, 2026
    Annual report (foreign issuer) 20-F · period to December 31, 2025Revenue rose 50% to $566.1M versus the prior year; diluted EPS $0.10 versus $0.06.
  4. March 18, 2026
  5. March 13, 2026
  6. December 31, 2025
  7. November 14, 2025
  8. August 22, 2025
  9. May 16, 2025
  10. April 17, 2025
    Annual report (foreign issuer) 20-F · period to December 31, 2024Revenue rose 69% to $376.6M versus the prior year; diluted EPS $0.06 versus $0.06.

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 4, 2026. Insider transactions on SEC

Insider trades

What the people running RLX Technology Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns RLX

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Ying (Kate) Wang13G, passive with 5 related filers 51.2% 793,057,297 March 18, 2026

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 104 managers reported a position.

HolderSharesValueChange on quarter
First Beijing Investment Ltd59,821,839$113.7M-307,832
IDG China Venture Capital Fund V Associates L.P.55,074,473$104.6M-2,058,530
Nomura Holdings Inc22,583,602$42.9M+20,221,393
Vanguard Capital Management LLC20,925,425$39.8M-546,627
OLP CAPITAL MANAGEMENT Ltd13,322,760$25.3M-13,052,670
BlackRock, Inc.9,634,820$18.3M+109,933
D. E. Shaw & Co., Inc.9,550,710$18.1M-59,275
Perseverance Asset Management International7,360,737$14M-135,125
Oasis Management Co Ltd.6,497,600$12.3M0
Barclays PLC6,048,550$11.5M0
Vanguard Fiduciary Trust Co5,645,844$10.7M+28,425
Pictet Asset Management Holding SA3,933,703$7.5M+181,359
Morgan Stanley3,906,504$7.4M-1,861,603
State Street Corp2,993,983$5.7M-333,677
Bank of America Corp2,457,161$4.7M+7,453
Two Sigma Investments, LP2,343,695$4.5M+1,715,872
Goldman Sachs Group Inc2,172,378$4.1M-36,324
Connor, Clark & Lunn Investment Management Ltd.2,157,166$4.1M-2,623
Capitolis Liquid Global Markets LLC1,510,200$2.9M0
Assenagon Asset Management S.A.1,455,020$2.8M+703,023

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

No insider reported holdings on a Form 4 in the last 12 months.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about RLX

What does RLX Technology Inc. do?

RLX Technology Inc. is a company in the Health care sector, listed on NYSE as RLX. Its shares trade on NYSE under the ticker RLX.

What is RLX Technology Inc.'s net worth?

RLX Technology Inc. has a market value (market cap) of $2.5B at the latest share price, and shareholders' equity of $2.2B on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is RLX Technology Inc. profitable?

Yes. In fiscal 2025 it reported net income of $131.8M on revenue of $566.1M, a net margin of 23.3%.

How much revenue does RLX Technology Inc. make?

In fiscal 2025 RLX Technology Inc. reported revenue of $566.1M. That is 50.3% more than a year earlier.

When did RLX Technology Inc. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on April 23, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from August 14, 2026.

Does RLX Technology Inc. pay a dividend?

Yes. RLX Technology Inc. declared dividends of $0.11 per share in fiscal 2025.

Similar companies

Compare RLX with

Compare RLX with any company

Follow RLX

Get an email when RLX Technology Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when RLX files with the SEC.

Where the numbers come from

Financial figures are the values RLX Technology Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.